poisar

Stock

Anbio Biotechnology NNNN

$3.89+1.57%

Overview

NNNN market data

Business OverviewA provider-written description of this company or fund, with its source and observation date.

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).

Official website

Source
massive
Observed
Cadence
Reference data reviewed periodically
Status
fresh

Price HistoryDaily closing prices from recorded market data. The latest point represents the most recent completed daily period; prices can move before the next point appears.

NNNN price chart · 1M
O
3.90
H
3.94
L
3.89
C
3.89
Vol
930.00

Daily history from Feb 19, 2025

Source
US equities market feed
Observed
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & PerformanceOpen, range, return and notional-volume facts calculated from daily market bars.

Open
$3.90
Previous Close
$3.83
Day High
$3.94
Day Low
$3.89
52 Week High
$42.83
52 Week Low
$3.09
7 Day Return
-2.99%
30 Day Return
+15.09%
90 Day Return
-53.30%
1 Year Return
-72.33%
Daily Notional Volume
$3.6K
Latest daily bar volume multiplied by its closing price.

Valuation & ProfitabilityProvider-backed valuation, profitability, and range metrics for the selected company. Display-only; never feeds scores or decisions.

Provider-backed
P/E (TTM)
53.88
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
—
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
$0.15
Diluted earnings per share over the trailing twelve months.
Beta
1.97
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
—
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
77.1%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$3.09 – $44.73
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
—
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $549.7M · P/B 143.49 · P/S 41.54.

Company NewsRecent source-attributed headlines linked to this symbol. Repeated headlines and low-signal items are filtered. Open a headline for its source and context.

2 captured

Decision & ScoreThis analysis is included with a paid membership. Public prices, charts and source-attributed news remain available without a subscription. Membership does not guarantee an investment outcome.

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern EvidenceThis analysis is included with a paid membership. Public prices, charts and source-attributed news remain available without a subscription. Membership does not guarantee an investment outcome.

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer RankingThis analysis is included with a paid membership. Public prices, charts and source-attributed news remain available without a subscription. Membership does not guarantee an investment outcome.

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock